[Problems and prospects of vitiligo study].
D000302:Adrenal Cortex / Q000503:physiopathology; D000818:Animals; D001327:Autoimmune Diseases / Q000209:etiology; D001679:Biogenic Amines / Q000502:physiology; D000242:Cyclic AMP / Q000502:physiology; D005260:Female; D006801:Humans; D008543:Melanins / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D009074:Melanocyte-Stimulating Hormones / Q000502:physiology; D008544:Melanocytes / Q000378:metabolism; D008550:Melatonin / Q000502:physiology; D011247:Pregnancy; D012880:Skin Pigmentation; D013438:Sulfhydryl Compounds / Q000378:metabolism; D013961:Thyroid Gland / Q000503:physiopathology; D013963:Thyroid Hormones / Q000502:physiology; D014443:Tyrosine / Q000378:metabolism; D014820:Vitiligo / Q000209:etiology* / Q000378:metabolism
D001679:Biogenic Amines; D008543:Melanins; D013438:Sulfhydryl Compounds; D013963:Thyroid Hormones; D014443:Tyrosine; D009074:Melanocyte-Stimulating Hormones; D000242:Cyclic AMP; D008550:Melatonin
Problemy i persepktivy izucheniia vitiligo.